Butyrate limits inflammatory macrophage niche in NASH
Open Access
- 18 May 2023
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (5) , 1-11
Abstract
Immune cell infiltrations with lobular inflammation in the background of steatosis and deregulated gut-liver axis are the cardinal features of non-alcoholic steatohepatitis (NASH). An array of gut microbiota-derived metabolites including short-chain fatty acids (SCFA) multifariously modulates NASH pathogenesis. However, the molecular basis for the favorable impact of sodium butyrate (NaBu), a gut microbiota-derived SCFA, on the immunometabolic homeostasis in NASH remains elusive. We show that NaBu imparts a robust anti-inflammatory effect in lipopolysaccharide (LPS) stimulated or classically activated M1 polarized macrophages and in the diet-induced murine NASH model. Moreover, it impedes monocyte-derived inflammatory macrophage recruitment in liver parenchyma and induces apoptosis of proinflammatory liver macrophages (LM) in NASH livers. Mechanistically, by histone deactylase (HDAC) inhibition NaBu enhanced acetylation of canonical NF-κB subunit p65 along with its differential recruitment to the proinflammatory gene promoters independent of its nuclear translocation. NaBu-treated macrophages thus exhibit transcriptomic signatures that corroborate with a M2-like prohealing phenotype. NaBu quelled LPS-mediated catabolism and phagocytosis of macrophages, exhibited a differential secretome which consequently resulted in skewing toward prohealing phenotype and induced death of proinflammatory macrophages to abrogate metaflammation in vitro and in vivo. Thus NaBu could be a potential therapeutic as well as preventive agent in mitigating NASH.Keywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology (CRG/2019/001413)
- Council of Scientific and Industrial Research (MLP138)
This publication has 45 references indexed in Scilit:
- The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κBNucleic Acids Research, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Histone deacetylase 3 is an epigenomic brake in macrophage alternative activationGenes & Development, 2011
- Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophilsNature Immunology, 2011
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- Lipopolysaccharide triggers macrophage activation of inflammatory cytokine expression, chemotaxis, phagocytosis, and oxidative ability via a toll-like receptor 4-dependent pathway: Validated by RNA interferenceToxicology Letters, 2009
- Kupffer cells in non-alcoholic fatty liver disease: The emerging viewJournal of Hepatology, 2009
- Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1Journal of Lipid Research, 2006
- The role of IL-6 and STAT3 in inflammation and cancerEuropean Journal of Cancer, 2005
- Anti‐inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL‐12 and up‐regulation of IL‐10 productionThe FASEB Journal, 2000